New Recruiting Trial: Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
WHY IT MATTERS
This trial is specifically designed for women and girls with hemophilia A undergoing surgery — a population that often receives less research attention than males with the same condition.
This is a clinical trial testing a blood clotting medicine called Nuwiq in women and girls with hemophilia A who need surgery. Hemophilia A is a rare bleeding disorder where the body doesn't make enough of a protein that helps blood clot. The trial will study how well Nuwiq works and what dose is best for these patients during surgical procedures.
NCT ID: NCT05936580 Title: Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery Status: RECRUITING Phase: PHASE4 Sponsor: Octapharma Start date: 2026-04-01 URL: https://clinicaltrials.gov/study/NCT05936580 Source: UniteRare clinical trials database
YOU CAN ACT ON THIS
If you are a woman or girl with hemophilia A who may need surgery, check the trial website (clinicaltrials.gov/study/NCT05936580) to see if you meet eligibility requirements and contact the study team about enrolling.